DPYD and hyperinsulinemic hypoglycemia, familial, 4: DPD deficiency is therefore known to increase the risk of severe toxicity by two‐ to four‐fold and increase treatment‐related death by 25‐fold due to elevated systemic fluoropyrimidine exposure.5, 6, 7